DRUG · Unmapped registry intervention
D-serine
Find medicine records ·
Find other trials using this name
Clinical trial
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
NCT00237809
Study summary
ClinicalTrials.govD-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Cognitive Retraining (CRT)
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
BEHAVIORAL · Unmapped registry intervention
Cognitive Retraining Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
Sponsors & collaborators
Yale Universitylead sponsor
Donaghue Medical Research Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00237809 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.